5 Ways Big Data And AI Will Impact Life Sciences Firms In 2018

While industries such as financial services have had a long track record of managing data, and applying analytics to optimizing customer relationships and developing new services, life sciences companies have only in recent years begun to fully embrace and seize upon the opportunities to organize and apply their data in a systematic way to a range of drug development and patient care challenges.

As life science firms begin to actively mature their use of data, notable progress is being made in the efficiencies of drug development and the quality of insights produced at the research stage. However, given the accelerating rate of learning about human biology and disease processes, the opportunities to utilize data for even larger gains also continue to grow.

Author: Randy Bean and Grant Stephen


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s